Thermo Fisher Scientific trades -26.76% away from its average analyst target price of $659.08 per share. The 28 analysts ...

Genmab A/S trades -39.94% away from its average analyst target price of $31.0 per share. The 8 analysts following the stock ...

This divestiture is part of Leggett & Platt's ongoing strategic business review to determine the right long-term fit for the ...

BKR has a forward P/E ratio of 17.3 based on its forward 12 month price to earnings (EPS) of $2.57 per share Its Price to ...

These figures are in line with Rivian's previously stated outlook, where the company had projected production of ...

UMH Properties, Inc. is a public equity REIT that owns and operates 141 manufactured home communities, containing ...

In its 10-K report, nCino disclosed its financial condition and results of operations for fiscal 2025 and 2024. The company ...

Atlantic Union Bankshares Corporation has officially completed its merger with Sandy Spring Bancorp, Inc., creating the ...

Insmed has moved 160.1% over the last year, and the S&P 500 logged a change of 8.1% INSM has an average analyst rating of buy ...

BlackBerry Limited (NYSE: BB; TSX: BB) has released its financial results for the fourth quarter and full fiscal year 2025.

Denali Therapeutics Inc. (NASDAQ: DNLI) has announced the initiation of a rolling submission of a biologics license ...

Armour Residential REIT, Inc. has confirmed its April 2025 common share and Q2 2025 Series C preferred share dividends. For ...